Agios Pharmaceuticals Publishes Two Articles in Science Demonstrating the Effects of Mutant IDH1 and IDH2 Inhibitors in Primary Tumor Models
4/5/2013 9:53:27 AM
More...
|
Agios Pharmaceuticals Research in Cancer Metabolism Highlighted at American Association for Cancer Research Annual Meeting 2013
4/5/2013 6:52:38 AM
More...
|
Agios Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
2/26/2013 6:50:01 AM
More...
|
Agios Pharmaceuticals to Present IDH Program Insights at Tumor Metabolism Keystone Symposia
2/22/2013 11:24:16 AM
More...
|
New Publication in Science Shows That Agios Pharmaceuticals' IDH1 Inhibitor Can Reverse Cancer-Causing Effects of Oncometabolite 2-HG in Leukemia Model
2/13/2013 11:19:23 AM
More...
|
Agios Pharmaceuticals to Present at the Leerink Swann and Company 2013 Global Healthcare Conference
2/6/2013 6:56:15 AM
More...
|
Agios Pharmaceuticals to Present at 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 6:38:29 AM
More...
|
Agios Pharmaceuticals Publication Identifies First Potent Inhibitors of Mutant IDH1 that Lower Tumor Oncometabolite
10/11/2012 9:57:42 AM
More...
|
New Publications From Agios Pharmaceuticals Scientists and Collaborators Reveal Unexpected Regulation of Metabolic Pathways in Cancer
9/20/2012 10:06:11 AM
More...
|
Agios Pharmaceuticals to Present at the UBS Global Life Sciences Conference
9/13/2012 10:06:57 AM
More...
|
|